The study focused on a long-standing challenge in biotechnology. Streptomyces species grow as filamentous networks that, in liquid culture, form clumps or dense spherical pellets. Which of these growth forms is best for producing antibiotics has been debated for decades, and the answer varies from species to species. Pelleted growth boosted nikkomycin production in Streptomyces tendae and avermectin output in S. avermitilis, while dispersed growth favored geldanamycin in S. hygroscopicus and tylosin in S. fradiae. One established trick for steering morphology is microparticle-enhanced cultivation, in which tiny solid particles such as talc, aluminum oxide, or glass beads are added to cultures. These particles have previously increased production of valuable compounds, but the underlying mechanisms remain incompletely understood, and most studies have examined only a handful of model organisms.

Cellulose offered the team an intriguing alternative to the inorganic particles used before. Unlike talc or glass, cellulose fibers are larger, roughly 150 micrometers in this study, softer, less dense, and chemically distinct in their surface properties. Whether they would act through the same mechanisms as conventional particles was unknown, and no one had previously applied cellulose to engineer the morphology of filamentous bacteria. The researchers cultivated thirteen Streptomyces species, all free-living soil isolates with no detectable cellulose-degrading ability, in microtiter plates with and without 30 grams per liter of alpha-cellulose, then tracked growth, pellet size, and metabolite output.

The morphological effects were striking. Nine of the thirteen species normally form pellets, and in every one of those species the addition of cellulose significantly shrank the mean pellet diameter after six days of cultivation. In Streptomyces fradiae, the effect was so pronounced that the pellets disintegrated entirely, making quantification impossible. Other species showed subtler changes: S. cinereoruber transformed loose, open pellets into dense compact ones, while S. rimosus shifted from a uniform size distribution to a mixture of a few very large pellets and many small ones under 200 micrometers. The four naturally dispersed-growing species, by contrast, showed no visible morphological response at all.

The researchers propose that the likely mechanism is mechanical. Cellulose fibers colliding with mycelial aggregates repeatedly abrade their surfaces, knocking loose peripheral hyphae and preventing pellets from merging into larger composite structures. Because the fibers are too large to penetrate and loosen the pellet core, as smaller microparticles do in fungal fermentations, they act only from the outside. Their lower density and softer nature also mean they impose less force per contact than glass or ceramic beads. Another key difference is the inoculum: this study used dispersed mycelial fragments rather than spores, whereas many fungal microparticle studies rely on spore inoculation, where particles interfere with early spore aggregation. The standard mechanistic models developed for spore-based fungal cultivations, the authors caution, cannot simply be transplanted to these experiments.

To monitor growth in the presence of light-scattering cellulose fibers, which render conventional optical density measurements unreliable, the team turned to autofluorescence. Many Streptomyces produce fluorescent metabolic compounds, particularly flavins, whose glow can serve as a proxy for biomass. Comparing growth rates derived from autofluorescence and scattered light in particle-free cultures confirmed the two signals agreed for ten of the thirteen species. With cellulose present, initial growth rates dropped significantly in five species, but surprisingly this decline was not tied to morphology: both pelleted and dispersed species were affected. The area under the fluorescence curve, an integrated measure of growth over the whole cultivation, changed significantly in eight species, generally increasing. The authors caution that autofluorescence also reflects physiological state, since oxidized flavins fluoresce more strongly under carbon limitation, but it proved a valuable monitoring tool where scattered light failed.

The metabolic consequences were sobering for anyone hoping cellulose would be a universal productivity booster. Targeted analysis of known natural products revealed widespread declines. Oligomycin in S. avermitilis fell sevenfold, staurosporine in S. fradiae dropped elevenfold, daunomycin in S. coeruleorubidus halved, and rimocidin in S. albofaciens decreased 1.3-fold. In S. bobili, two anthracycline antibiotics, aclacinomycin T and aclacinomycin A, vanished below the detection limit entirely. Only S. rimosus bucked the trend among pelleted species: its rimocidin levels held steady, and its tetracycline output actually rose 1.5-fold, echoing an earlier report that talc addition boosted oxytetracycline in the same species. The contrasting responses of tetracycline in S. rimosus and S. albofaciens, which fell 1.9-fold in the latter, underline how species-specific these regulatory networks are.

Untargeted metabolomics across all thirteen species added a deeper layer of insight. Principal component analysis showed that species identity, not cellulose treatment, was the dominant driver of metabolic variation, though some species, notably S. rimosus and S. albofaciens, shifted markedly in response to the fibers. Remarkably, when grown without cellulose, the metabolomes of the species mirrored their biosynthetic potential: a statistical comparison of biosynthetic gene cluster repertoires, mined with antiSMASH, and metabolic profiles yielded a significant Mantel correlation of about 0.578, and the trees aligned with an entanglement value of just 0.04. In other words, bacteria with similar genetic toolkits for making natural products produce chemically similar metabolomes. With cellulose present, that elegant correlation collapsed entirely, suggesting a broadly shared stress response that overwrites each species’ biosynthetic fingerprint.

The linear model identified 428 significantly altered metabolites, 250 depleted and 178 enriched with cellulose. Peptides dominated the depleted fraction, appearing across as many as all thirteen species, likely reflecting disrupted programmed cell death and autolysis that normally supply nutrients during stationary phase and sporulation. Enriched metabolites included amino acids, lipids, nucleosides, and hydrophobic scaffolds, consistent with mechanical damage rupturing dying cells and spilling their contents into the medium, alongside 27 features of unknown identity and several putative polyketides hinting at genuinely novel chemistry. The strongest responders were loose-pellet formers such as S. albofaciens, S. bobili, and S. avermitilis, while dense-pellet and dispersed species changed little. Filter paper assays confirmed the effects were not due to cellulose digestion by the bacteria.

The authors conclude that cellulose-induced mechanical stress causes a profound, species-dependent metabolic reprogramming, likely through increased cell degradation rather than enhanced productivity, and they see promise in a more ambitious direction: pairing these cellulose-sensitive Streptomyces with cellulolytic fungi such as Trichoderma reesei, whose slow glucose release and cell wall signals could create metabolic dependency and push the bacteria toward producing natural products they have never revealed. Whether cellulose effects scale to industrial stirred-tank bioreactors remains an open question, but the study establishes cellulose supplementation as a distinctive new lever for morphology engineering and suggests that some of the most elusive microbial metabolites may yield to a gentle abrasive nudge.

Subject of Research: The influence of cellulose particles on the growth, morphology, and metabolite production of thirteen Streptomyces species.

Article Title: Influence of Cellulose Particles on Streptomyces spp. Growth, Morphology, and Metabolite Spectrum

Article References: Schütterle, D. M., Al‐Smadi, B., Hemmann, J. L., Brauneck, G., Palacio‐Barrera, A. M., Schlembach, I., Schäuble, S., Magnus, J. B., Panagiotou, G., & Rosenbaum, M. A. (2026). Influence of Cellulose Particles on Streptomyces spp. Growth, Morphology, and Metabolite Spectrum. Microbial Biotechnology, 19(9), Article e70445. https://doi.org/10.1111/1751-7915.70445

Image Credits: AI Generated

DOI: 10.1111/1751-7915.70445

Keywords: Streptomyces, cellulose particles, microparticle-enhanced cultivation, secondary metabolites, morphology engineering, pellet size, untargeted metabolomics, biosynthetic gene clusters, autofluorescence monitoring, natural products, antibiotic discovery, bioprocess engineering

Metabolomics is designed to capture the small molecules that reflect what cells are doing at a particular moment. Unlike genomics, which describes biological potential, metabolomics records the chemical consequences of genetics, diet, exercise, disease, medication and environmental exposure. Liquid chromatography–tandem mass spectrometry, or LC–MS/MS, is one of the field’s most powerful tools. In this technique, liquid chromatography separates compounds according to their chemical interactions with a column, while mass spectrometry measures their mass-to-charge ratios and fragments selected molecules to generate structural clues. The resulting data contain thousands of peaks, each representing an ionized molecular feature. Some can be matched to reference standards or spectral libraries. Others have an accurate mass and perhaps a molecular formula, but no secure name, structure or biological interpretation.

The problem is more complicated than simply searching a larger database. Two compounds can share the same molecular formula while having different arrangements of atoms, known as structural or positional isomers. Stereoisomers can also possess the same connectivity but differ in three-dimensional orientation. These molecules may produce nearly identical masses and overlapping fragmentation patterns, while behaving differently in the chromatographic system and exerting different effects in the body. Unknown signals may also arise from chemical transformations that are poorly represented in databases, including compounds generated by gut microbes, noncanonical biochemical reactions or exposure to external chemicals. Instrumental artifacts, such as in-source fragmentation and ion rearrangement, can further create peaks that resemble genuine metabolites. As a result, a formula match alone is rarely enough to support a biologically meaningful annotation.

The researchers addressed this challenge by first defining the chemical landscape of the biological dataset itself. Their test data came from a randomized controlled trial investigating exercise during pregnancy in women with obesity. Plasma samples were collected from 119 sedentary pregnant participants, including women assigned to a combined aerobic and resistance-training program and others receiving standard care. In total, 235 samples were analyzed, including samples collected after submaximal exercise assessments. The study was not primarily intended to compare exercise and control groups in the present analysis. Instead, it provided a biologically relevant collection of plasma metabolites in which to develop and evaluate a strategy for interpreting unknown LC–MS features.

The samples were analyzed in both positive and negative electrospray ionization modes using an Orbitrap Exploris 480 mass spectrometer coupled to ultra-high-performance liquid chromatography. The instrument acquired high-resolution full-scan data across broad mass ranges and tandem spectra from pooled quality-control samples. After filtering for mass accuracy, signal quality, reproducibility and background contamination, the researchers retained 2,857 metabolite features. Of these, 1,021 had some level of annotation, ranging from relatively strong matches supported by an in-house standard and retention time to weaker assignments based only on accurate mass or molecular formula. The remaining 1,836 features lacked a chemical identity and were designated as metabolic dark matter. Rather than treating the partially annotated compounds as proven identifications, the researchers used them as landmarks defining regions of chemically plausible space.

To organize those landmarks, the team grouped the 1,021 known or partially characterized metabolites into ten structurally coherent clusters. The clustering process used molecular fingerprints, digital representations of the substructures present in each molecule. Specifically, the researchers generated Morgan circular fingerprints from SMILES chemical notation using the RDKit cheminformatics toolkit. These fingerprints encode local atomic environments as binary vectors. Structural similarity between two molecules was then measured with the Tanimoto coefficient, calculated from the number of shared fingerprint features relative to the total features present in either molecule. A score of 1 indicates identical fingerprint representations, while a score approaching 0 indicates little overlap. Importantly, the score reflects two-dimensional structural similarity and does not establish identical stereochemistry, tautomeric state or biological activity.

The next stage began with a deliberately broad search. For each of the 1,836 unannotated features, the researchers used its predicted molecular formula and molecular weight to retrieve possible structures from PubChem, allowing a relatively generous mass tolerance of plus or minus 0.5 daltons. This produced 569,115 candidate entries. After removing duplicates, malformed structures and records without usable chemical representations, 368,197 unique structures remained. The candidates were compared with the ten known-metabolite clusters, and those with Tanimoto similarity scores between 0.50 and 1.00 were retained. The lower threshold was intentionally permissive: a score of 0.5 was treated as evidence of a potentially useful chemical relationship, not as proof of identity. More stringent thresholds of 0.6 and 0.7 were also examined to show how the shortlist changed under increasingly conservative assumptions.

Similarity alone still left too many possibilities, so the researchers added a second, independent clue: retention time. In LC–MS, retention time is the point at which a compound emerges from the chromatography column. It depends on physicochemical properties such as hydrophobicity, polarity, hydrogen bonding and interactions with the stationary phase. Positional isomers with the same formula and mass may therefore separate at different times. The team used machine-learning models to predict retention times for candidate structures and compared those predictions with experimentally observed retention times for the unknown features. Candidates received higher priority when their predicted chromatographic behavior agreed with the measured signal. This step was especially valuable for distinguishing isomers that could not be separated confidently by formula matching or conventional spectral similarity.

Combining structural neighborhoods and retention-time agreement reduced the candidate space to 418 high-confidence candidate annotations. Among these, 83 were additionally supported by cross-referencing the Human Metabolome Database and the LIPID MAPS Structure Database. The final candidates were also placed in biological context through analyses involving absorption, distribution, metabolism and excretion properties, predicted protein targets, molecular docking and mapping to Kyoto Encyclopedia of Genes and Genomes pathways. Those analyses were applied to the known metabolites used to establish the reference landscape, helping the researchers interpret which chemical families and biological processes were represented in the dataset. The framework could thus prioritize not only molecules that resemble known compounds, but also candidates that fit the chemical and physiological environment of the samples.

The method is not a replacement for authentic standards, high-quality reference spectra or direct structural confirmation. A candidate structure that matches a formula, resembles a known metabolite and has a compatible retention time can still be wrong, particularly when stereoisomers or unusual ion forms are involved. The PubChem search tolerance was also broad enough to generate many chemically implausible possibilities before filtering, and the Tanimoto coefficient does not capture every aspect of molecular behavior. In addition, the test dataset came from a specific population and analytical platform, so retention-time models trained or calibrated in one laboratory may not transfer perfectly to another instrument, column or solvent gradient. Even so, the workflow provides a practical way to decide which unknown signals deserve scarce experimental resources first.

The broader significance is that metabolic dark matter is no longer being treated solely as an obstacle caused by incomplete databases. Unknown features can be interpreted as members of chemical neighborhoods, assessed according to how they travel through a chromatographic system and connected to biological pathways that may explain their origin or importance. By integrating formula-based retrieval, molecular fingerprints, retention-time prediction and biological context, the framework creates an auditable chain of reasoning between an unexplained mass-spectrometry peak and a testable molecular hypothesis. If validated with authentic standards and expanded across tissues, diseases, diets and environmental exposures, such approaches could accelerate the discovery of previously overlooked biomarkers and signaling molecules. For metabolomics, the viral idea is simple: thousands of mysterious peaks may not be noise waiting to be discarded, but clues waiting for the right combination of chemistry, computation and biology.

PCOS is associated with a range of symptoms, including irregular menstrual cycles, infertility, and metabolic disturbances. Despite its widespread occurrence, the underlying metabolic pathways remain poorly understood. The impetus for this study is clear: to stitch together the fragmented narrative of PCOS through the lens of metabolomics, which analyzes metabolites in biological samples. The hope is to illuminate pathways that can be exploited for diagnosis and treatment.

Utilizing mass spectrometry, a method renowned for its precision and sensitivity, the researchers have set out to analyze a diverse array of metabolites present in biological samples from women with PCOS. This technique not only identifies known metabolites but also captures novel compounds that may play a significant role in the disorder. By employing untargeted metabolomics, the study circumvents the constraints of hypothesis-driven research, opening doors to unanticipated discoveries.

In their detailed investigation, the research team collected serum samples from a cohort of women diagnosed with PCOS, alongside samples from healthy controls. The analysis focused heavily on quantifying the metabolites associated with various biochemical cycles, thereby providing a comprehensive portrait of the metabolic dysregulation in PCOS. This approach stands to enhance our understanding of how metabolic pathways interact, potentially revealing systemic changes that contribute to the symptoms of PCOS.

The findings are particularly noteworthy. Preliminary results indicate significant alterations in the metabolic profiles of women with PCOS compared to the control group. These differences suggest unique metabolic signatures associated with the syndrome, which could pave the way for the identification of biomarkers for early diagnosis. Furthermore, the information gleaned from these profiles may inform the development of targeted therapies that address the root causes of the condition rather than merely its symptoms.

Notably, the study places a strong emphasis on the importance of personalized medicine. By harnessing the power of metabolomics, researchers argue for a tailored approach to treatment. Individual metabolic profiles could guide clinicians in selecting the most effective interventions for each patient, potentially improving treatment outcomes dramatically. This perspective challenges the traditional one-size-fits-all approach, advocating for a more nuanced understanding of metabolic disorders like PCOS.

As the research progresses, collaboration among scientists in the fields of endocrinology, gynecology, and metabolomics is anticipated to yield further insights. The interdisciplinary nature of this study is crucial, as it underscores the complexity of PCOS and the need for collaborative efforts to unravel its numerous facets. By bridging the gap between existing medical knowledge and emerging scientific techniques, the research fosters a holistic viewpoint on women’s health.

Moreover, this study is not operating in a vacuum. It is part of a larger trend where metabolomics is increasingly recognized for its potential to revolutionize our understanding of complex diseases. Public interest in health issues, especially those affecting women, highlights the urgency for innovative research efforts. As awareness of PCOS grows, so too does the hunger for actionable knowledge that can lead to improved health outcomes.

In summary, the mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome represents a pivotal moment in our quest to understand and treat this prevalent endocrine disorder. By analyzing the metabolic changes associated with PCOS, researchers stand at the crossroads of discovery and application, promising a future where personalized treatment options could become a reality for millions of women affected by this condition. The ongoing research efforts are highly anticipated and set the stage for transformative advancements in both diagnostics and therapy.

As the findings from this study are disseminated, the scientific community remains hopeful that these insights will foster further investigation into the metabolic underpinnings of PCOS. Continued research will play a critical role in refining our understanding and ultimately leading to better health management strategies for individuals living with this challenging syndrome. The future holds promise, and the integration of cutting-edge technology with earnest scientific inquiry reflects the dedication to improving women’s health.

The implications of this work extend beyond the confines of the laboratory. Should the proposed biomarkers be validated, they may redefine clinical practices currently used to diagnose and treat PCOS. Moreover, public health initiatives could be informed by such research, potentially leading to earlier interventions and improved health literacy among women regarding this disorder. This engenders a sense of urgency in pursuing such ground-breaking research avenues, underlining the potential for substantial societal impact.

As we look ahead, it will be crucial to monitor the progress of the metabolic discoveries stemming from this research. The adaptive nature of metabolomics positions it as a vital tool for ongoing investigations into various health conditions, reinforcing the interconnectedness of metabolic health and overall well-being. Each new finding contributes to a growing body of knowledge that can redefine how we approach women’s health in the future.